| http://www.w3.org/ns/prov#value | - For example, two RCTs of carvedilol, a vasodilatory beta-blocker, in chronic heart failure excluded 6% and 9% of eligible patients in treatment run-in periods???mainly because of worsening heart failure and other adverse events, some of which were fatal [1].
|
